Table 2 Treatments in the last 12 months and baseline status between RCBD and NRCBD. Significance with Bonferroni correction requires p < 0.0012 (0.05/41)
Variables | Total (n = 520) | RCBD (n = 49) | NRCBD n = 471) | t/Z/χ2 | P |
|---|---|---|---|---|---|
Number of psychotropic medications | Â | Â | Â | - | 0.7004 |
 No medication | 10(1.92) | 1(2.04) | 2(1.91) |  |  |
 One medication | 15(2.88) | 1(2.04) | 14(2.97) |  |  |
 Two medications | 89(17.12) | 11(22.45) | 78(16.56) |  |  |
 Three and more medications | 406(78.08) | 36(73.47) | 370(78.56) |  |  |
 Mood stabilizers | 476(91.5) | 46(93.9) | 430(91.3) | - | 0.7869 |
 Lithium | 270(51.9) | 24(49.0) | 246(52.2) | 0.1878 | 0.6648 |
 Valproic acid | 319(61.4) | 32(65.3) | 287(60.9) | 0.3578 | 0.5498 |
 Carbamazepine | 1(0.2) | 0(0.0) | 1(0.2) | - | 1.0000 |
 Lamotrigine | 44(8.5) | 8(16.3) | 36(7.6) | - | 0.0539 |
Number of mood stabilizers | Â | Â | Â | - | 0.3246 |
 One mood stabilizer | 325(62.5) | 30(61.2) | 295(62.6) |  |  |
 Two mood stabilizers | 144(27.7) | 14(28.6) | 130(27.6) |  |  |
 Three mood stabilizers | 7(1.4) | 2(4.1) | 5(1.1) |  |  |
 Antipsychotics | 440(84.62) | 41(83.67) | 399(84.71) | 0.0369 | 0.8477 |
 Antidepressants | 206(39.62) | 22(44.90) | 184(39.07) | 0.6311 | 0.4270 |
 Benzodiazepines | 93(17.88) | 10(20.41) | 83(17.62) | 0.2346 | 0.6281 |
 ECT during hospitalization in the last 12 months (n = 348) | 98(28.2) | 3(11.1) | 95(29.6) | 4.2060 | 0.0403 |
 MDQ Part 1 scores (Mean ± SE) | 3.13 ± 3.19 | 3.92 ± 2.93 | 3.04 ± 3.21 | 5.5477 | 0.0105 |
 QIDS-SR16 score (Mean ± SE) | 7.75 ± 5.47 | 9.10 ± 5.05 | 7.60 ± 5.49 | 5.1690 | 0.0230 |